MX2019012070A - Vacunas contra el gallid herpesvirus 3 recombinante que codifican antigenos patogenicos aviares heterologos. - Google Patents

Vacunas contra el gallid herpesvirus 3 recombinante que codifican antigenos patogenicos aviares heterologos.

Info

Publication number
MX2019012070A
MX2019012070A MX2019012070A MX2019012070A MX2019012070A MX 2019012070 A MX2019012070 A MX 2019012070A MX 2019012070 A MX2019012070 A MX 2019012070A MX 2019012070 A MX2019012070 A MX 2019012070A MX 2019012070 A MX2019012070 A MX 2019012070A
Authority
MX
Mexico
Prior art keywords
avian
gallid herpesvirus
recombinant gallid
pathogen antigens
encoding heterologous
Prior art date
Application number
MX2019012070A
Other languages
English (en)
Inventor
Sadigh Yashar
Nair Venugopal
Original Assignee
The Pirbright Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Pirbright Inst filed Critical The Pirbright Inst
Publication of MX2019012070A publication Critical patent/MX2019012070A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención se refiere a un vector recombinante del Gallid herpesvirus 3 que codifica antígenos patogénicos aviares heterólogos que comprende uno o más polinucleótidos heterólogos insertados en los loci intergénicos UL3/UL4 y/o UL21/UL22. La invención se refiere además a vacunas que comprenden dicho vector recombinante del Gallid herpesvirus 3 y, opcionalmente, un vector adicional del virus de la enfermedad de Marek y a un uso de la vacuna para proteger una especie aviar contra uno o más patógenos aviares. Se proporcionan procedimientos adicionales para tratar una especie aviar para protección contra una o más enfermedades causadas por patógenos aviares y un procedimiento de producción del vector recombinante del Gallid herpesvirus 3 que codifica antígenos patogénicos aviares heterólogos.
MX2019012070A 2017-04-21 2018-04-20 Vacunas contra el gallid herpesvirus 3 recombinante que codifican antigenos patogenicos aviares heterologos. MX2019012070A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17167638.0A EP3391903B1 (en) 2017-04-21 2017-04-21 Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens
PCT/EP2018/060225 WO2018193110A1 (en) 2017-04-21 2018-04-20 Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens

Publications (1)

Publication Number Publication Date
MX2019012070A true MX2019012070A (es) 2019-12-16

Family

ID=58632236

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012070A MX2019012070A (es) 2017-04-21 2018-04-20 Vacunas contra el gallid herpesvirus 3 recombinante que codifican antigenos patogenicos aviares heterologos.

Country Status (13)

Country Link
US (2) US20200121785A1 (es)
EP (2) EP3391903B1 (es)
JP (1) JP2020517307A (es)
KR (1) KR20200002834A (es)
CN (1) CN110536697A (es)
AU (1) AU2018255381A1 (es)
BR (1) BR112019021638A2 (es)
CA (1) CA3059656A1 (es)
CL (1) CL2019002964A1 (es)
CO (1) CO2019011548A2 (es)
MX (1) MX2019012070A (es)
RU (1) RU2019136150A (es)
WO (1) WO2018193110A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109320594B (zh) * 2018-11-13 2021-09-28 四川大学 一种禽传染性支气管炎和新城疫的病毒样颗粒、制备方法及应用
CN109762941B (zh) * 2019-02-14 2021-06-29 中国动物卫生与流行病学中心 一种检测致禽类死亡病原的液态芯片
CN111041004A (zh) * 2019-12-31 2020-04-21 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种表达新城疫病毒f蛋白的传染性喉气管炎重组病毒株及其构建方法和应用
US11299517B2 (en) * 2020-04-15 2022-04-12 The United States Of America, As Represented By The Secretary Of Agriculture Recombinant vaccine against Marek's disease and Newcastle disease
IL299033A (en) * 2020-06-17 2023-02-01 Boehringer Ingelheim Vetmedica Gmbh Recombinant HVT vectors expressing influenza hemagglutinin and immunogenic compounds, production and uses thereof
CN112048484A (zh) * 2020-07-27 2020-12-08 华南农业大学 一株表达传染性法氏囊强毒株vp2蛋白的基因ⅶ型新城疫重组病毒和疫苗
CN111910019A (zh) * 2020-08-04 2020-11-10 广东省实验动物监测所 一种检测鸡传染性喉气管炎病毒rpa扩增方法
CN111909965A (zh) * 2020-08-06 2020-11-10 中国兽医药品监察所 一种表达传染性法氏囊病病毒vp2蛋白重组病毒载体的构建与应用
EP3950948A1 (en) * 2020-08-07 2022-02-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Platform vector for modular and simplified insertion of transgenes into alphaherpesvirinae
WO2023177620A1 (en) * 2022-03-14 2023-09-21 University Of Georgia Research Foundation, Inc. Live mycoplasma synoviae vaccine
WO2023196374A1 (en) * 2022-04-06 2023-10-12 University Of Georgia Research Foundation, Inc. Live mycoplasma gallisepticum vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4111403B2 (ja) 1996-10-11 2008-07-02 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 免疫刺激ポリヌクレオチド／免疫調節分子複合体
EP2768529A1 (en) 2011-10-21 2014-08-27 Intervet International B.V. Recombinant nonpathogenic mdv vector providing multivalent immunity
SI2785373T1 (sl) * 2011-11-30 2020-02-28 Boehringer Ingelheim Animal Health USA Inc. Rekombinantni vektorji HVT, ki izražajo antigene aviarnih patogenov in uporabe le-teh
US9101598B2 (en) * 2011-11-30 2015-08-11 Merial, Inc. Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
BR112018002887A2 (pt) 2015-08-10 2018-11-06 The Texas A & M University System vacinas de herpesvirus recombinantes de peru e seus usos

Also Published As

Publication number Publication date
CN110536697A (zh) 2019-12-03
CL2019002964A1 (es) 2020-02-21
EP3391903B1 (en) 2022-02-23
CA3059656A1 (en) 2018-10-25
US20200121785A1 (en) 2020-04-23
JP2020517307A (ja) 2020-06-18
EP3391903A1 (en) 2018-10-24
WO2018193110A1 (en) 2018-10-25
KR20200002834A (ko) 2020-01-08
RU2019136150A (ru) 2021-05-21
AU2018255381A1 (en) 2019-10-17
CO2019011548A2 (es) 2020-02-28
US20220105174A1 (en) 2022-04-07
EP3612220A1 (en) 2020-02-26
BR112019021638A2 (pt) 2020-05-12
RU2019136150A3 (es) 2021-11-15

Similar Documents

Publication Publication Date Title
MX2019012070A (es) Vacunas contra el gallid herpesvirus 3 recombinante que codifican antigenos patogenicos aviares heterologos.
MX2018014573A (es) Vacuna contra el virus del zika.
PH12019501366A1 (en) Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
CY1122872T1 (el) Ανασυνδυασμενοι hvt φορεις οι οποιοι εκφραζουν αντιγονα παθογονων των πτηνων και χρησεις αυτων
EP4104854A3 (en) Multivalent vaccines for rabies virus and coronaviruses
TW201613558A (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
PH12019501766A1 (en) Porcine coronavirus vaccines
BR112014024094A2 (pt) vírus do herpes aviário recombinante, vacina multivalente, método para a vacinação de uma ave simultaneamente contra pelo menos dois patógenos, antissoro direcionado contra o vírus do herpes aviário, e kit de vacinação para a imunização de espécies de aves
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
PH12019500592A1 (en) New swine influenza vaccine
PH12019500854A1 (en) Recombinant vectors expressing antigens of avian influenza virus and uses thereof
WO2017044895A3 (en) MVA-gH/gL-PC VACCINE DERIVED ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS INFECTIVITY AND METHODS THEREOF
ZA201707985B (en) Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
MX2018001815A (es) Vacunas de herpesvirus de pavo recombiante y uso de las mismas.
MX2022002994A (es) Vectores de herpesvirus de los pavos recombinante que expresan antígenos de patógenos aviares y usos de estos.
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
MX2019013154A (es) Vacuna contra la enfermedad respiratoria bovina.
MX2017000209A (es) Composicion de lhrh inmunogenica y uso de la misma en cerdos.
MX2021004907A (es) Vacuna de ibv 4/91 con proteina espicular heterologa.
MX2022004869A (es) Vacuna de particulas similares al virus chikungunya y metodos de uso de la misma.
TN2014000393A1 (en) Modified marek's disease virus, and vaccines made therefrom
RU2015108739A (ru) Быстрая неиммунная защита - новая стратегия вакцинопрофилактики инфекционных болезней
PH12020550948A1 (en) Vaccines against hendra and nipah virus infection